Leukemia Clinical Trials

Showing 6521-6540 of 8,366 trials

Study of Treatment With Nilotinib in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase

NCT00786812

Maintain and monitor long-term hematological and cytogenetic responses previously obtained by patients participating in the \[CAMN107A2109\] study

Chronic Myeloid Leukemia

Novartis Pharmaceuticals89 participantsStarted Aug 2008

Belo Horizonte, Minas Gerais, Brazil • Curitiba, Paraná, Brazil • Rio de Janeiro, Rio de Janeiro, Brazil +6 more locations

COMPLETEDNA

Parathyroid Allo-transplantation With a New Technique

NCT02134483

Parathyroid allo-transplantation (PA-t) is a valuable alternative in the treatment of permanent hypoparathyroidism. However, it is a difficult process that requires a number of trained staff and advanced laboratory equipment which bring high costs. In this study, we have identified a new PA-t technique.

Parathyroid Allo-transplantation

Erhan Aysan7 participantsStarted Sep 2013

Istanbul, Istanbul, Turkey (Türkiye)

COMPLETEDPhase 2

Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes

NCT00171912

This trial is for various types of malignancies which may depend on certain enzymes (tyrosine kinases) for growth. The objective of this study is to assess to what extent imatinib mesylate blocks these enzymes and to assess the effect on the malignancy.

Hypereosinophilic SyndromeSystemic MastocytosisChronic Myelomonocytic Leukemia+1 more

Novartis Pharmaceuticals38 participantsStarted Sep 2004

East Melbourne, Australia

Study of Treatment With Nilotinib in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase

Parathyroid Allo-transplantation With a New Technique

Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes

Related Searches

Evaluation of Preimplantation Portal Vein and Hepatic Artery Flushing With Tacrolimus

Study Comparing Standard Dose and High-dose Imatinib Mesylate in Patients With Chronic Phase Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia (CML)

Zeushield Cytotoxic T Lymphocytes (Z-CTLs) for Relapsed or Refractory Non Small Cell Lung Cancer (NSCLC)

Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer

Alisertib for Acute Myeloid Leukemia

Is Chronic Abdominal Pain in Pediatric Patients Due to Small Intestinal Bacterial Overgrowth?

A Prospective, Interventional Study Assessing Response to Cytarabine, Daunorubicin and Etoposide (ADE) for First Relapse of Paediatric Acute Myeloid Leukemia

Adjuvant Pembrolizumab in N2 Positive Non-small Cell Lung Cancer Patients

CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant

A Quality Improvement Approach to the Management of Chronic Lymphocytic Leukemia

Study of Ibrutinib Followed by Ibrutinib in Combination With Nivolumab in Non-Small Cell Lung Cancer (NSCLC)

Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors

D1 Versus D2 Lymphadenectomy in High Risk Elderly With Gastric Adenocarcinoma

University of Wisconsin Solution Versus New Parathyroid Transport Solution for Parathyroid Allotransplantation

FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer

Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy

Study of the Glutaminase Inhibitor CB-839 in Leukemia